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ABSTRACT 
Conventionally, NSAID has been proposed to have inhibitory action against 
COX and therefore has traditionally been used for treatment of acute and chronic 
inflammation. This study aims at exploring putative anti-inflammation mechanism of 
acerola. Previous studies have illustrated that phytochemicals like alkaloids, terpenoids, 
flavonoids, curcumin and phenolics have COX inhibitory activities as well. However, a 
natural occurring selective inhibitor of COX-2 that can modulate inflammation and can 
overcome the limitations of drugs like aspirin is still a priority. Aspirin is known to form 
an irreversible and non-competitive binding to COX which proves to be a potent 
cardiovascular protective agent. On the other hand, irreversible binding has implications 
by initiating inhibition of blood platelet aggregation. 
 Acerola has been earlier studied for its antioxidant, antimicrobial, anti-
inflammatory, anticancer, antigenotoxic and antihyperglycemic properties. In the present 
study, anti-inflammatory properties of acerola have been established where different 
genotypes of acerola fruit and leaf fractions were studied for their biological properties. 
A comparative study using TLC, LC-MS and bioassays using macrophages is employed 
to identify which groups of phytochemicals are responsible for scavenging and 
inflammation inhibitory effect of acerola. Initially, phytochemicals were extracted using 
methanolic and methanolic/acetone/water solvents which isolated different groups of 
compounds in two fractions, including polyphenols and a mixture of 
polyphenols/terpenoids, respectively. The two fractions were explored to elucidate mode 
of action for different acerola genotypes. Results indicated that the methanolic fractions 
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of acerola showed higher activity exhibited suppression of ROS and partial decrease of 
nitric oxide levels in LPS-stimulated RAW264.7 macrophage cell line. This fraction also 
demonstrated inhibition of enzyme expression of COX-1/2. Moreover, BRS-238, a ripe 
fruit genotypes of acerola had a selective action against COX-2 - confirming the 
hypothesis that acerola’s mode of anti-inflammatory action is through selective 
inhibition of COX-2.  
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CHAPTER I 
INTRODUCTION 
Phytochemicals are naturally occurring plant derived compounds that account for 
bitterness, astringency, color, flavor, odor and oxidative stability in foods. They include 
carotenoids, lycopenes, flavonoids, anthocyanins, terpenoids, polyphenols etc. 
Epidemiological studies have illustrated that intake of these phytochemicals have 
an inverse correlation with obesity, diabetes, hepatitis B, cardiovascular diseases, 
neurodegenerative diseases and HIV 
1-10
. They are known to possess antioxidant 
properties and have been identified to scavenge singlet oxygen ions, peroxide 
decomposer, quencher of singlet oxygen radicals and electron donors. Therefore plants 
are called bio-factories of polyphenols 
1
. Phytochemicals are absorbed in the small 
intestine where they undergo series of hydrolysis before they are finally metabolized. 
After consumption of the foods polyphenols circulate in the blood plasma in their 
glucurinated or sulfated forms 
9, 10
. These oxidative stresses have been coupled with 
inflammatory studies. 
Inflammation is a central feature of metabolic syndrome. Inflammation is defined 
as a physiological response that triggers a defense mechanism against various stimuli. 
They may be categorized as systemic or localized according to the gravity of 
inflammatory reaction. Neutrophils play a pivitol role during the course of inflammation. 
They circulate within the blood stream and extravasates from the endothelial cell barrier 
in response to a mediator of inflammation 
11-14
.  
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MACROPHAGES AND INFLAMMATION 
Macrophages were first described by Noble laureate Élie Metchnikoff 
15
. As 
depicted from their name, they were previously thought to be involved in phagocytic 
functions; and were expected to possess an ability to stimulate phagocytosis at the port 
of inflammation. However, decades of research has demonstrated that these phagocytic 
cells have more functions than just defense mechanisms 
15, 16
. 
Several reports have amplified the role of macrophages in inflammation. 
Macrophages are essential in homeostasis 
15, 17
. They are omnipresent and circulate in 
the blood stream; either in response to stress in activated mode or to maintain the 
homeostasis in unstimulated state. They are involved in removal of the cell debris of the 
apoptotic cells through scavenger receptors like phosphotydl serine, thromobospondin, 
complementary receptors and integrin. These responses are independent and do not 
require signaling pathways to initiate cytokines or transcription of different genes 
16, 18
. 
 Macrophages are integral in identifying the endogenous danger signals through 
intracellular pattern recognition receptors and interleukin-1 receptors. Activated 
macrophages are further classified as M1 and M2 
16, 18
. M1 are the ones that are 
classically activated and induce proinflammatory cytokines, inducible nitric oxide and 
reactive nitrogen/oxygen intermediates. M1 promote tumorcidal and microbicidal 
activities 
17, 19
. Whereas M2 are alternately activated cells and helps in eradication of 
parasites by inducing IL-4 and IL-13 cytokines.  
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Interaction between metabolic cells and macrophages is cardinal for 
inflammation pathogenesis. During dysfunctions, recruitment process is intervened by 
pro-inflammatory cytokines and chemokines. Macrophages have specific roles that can 
be utilized for therapeutic purposes 
19
. Cytokines like IFN-γ are induced by innate or 
adaptive immune cells during endogenous stress. For example through LPS which 
transduces macrophages to secrete pro-inflammatory markers. Toll-like receptors (TLR) 
bind to the pathogen which induces transcription of various genes 
19-21
. 
MACROPHAGES INFILTRATION AND ACTIVATION 
Recruitment 
At the port of inflammation, a well-coordinated signaling pathway is initiated. 
Activation of macrophages is an essential step in pathogenesis of inflammation. 
Chemokines like monocyte chemoattractant protein-1 (MCP-1), also called as CC 
chemokine ligand-2, are produced at the site of dysfunction and they recruit 
macrophages. Studies have demonstrated that mice with knockout MCP-1 have higher 
insulin sensitivity and are protected from atherosclerosis 
17, 19
.  
Activation 
In the presence of external stimuli, the recruited macrophages begin host 
dependent signaling pathways to eradicate the cause of stress in the host. Therefore, they 
trigger an intrinsic or an extrinsic regulatory function. Overexpression of TNF-α, IFN-γ 
and iNOS traverses induction M1 macrophages which promotes pro-inflammatory 
markers. Whereas M2 phenotype of macrophages induce anti-inflammatory responses, 
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leading to production of IL-10, IL-13 and IL-4 causing wound healing, tissue repair and 
homeostasis 
17, 19
. 
Deactivation 
This is a critical step in restoring balance in the host; else pro-inflammatory 
markers will continue inducing an inflammatory response even after suppression of 
inflammation in the host tissues. The anti-inflammatory cytokines like IL-10 are 
produced to abort pro-inflammatory signals. Studies have established polymorphic 
nature of IL10 and its close association with metabolic syndrome 
22
. Anti-inflammatory 
cytokines mediate phagocytosis of the apoptotic cells and prevent systemic inflammation 
and necrosis. IL-10 is expressed in both M1 and M2 cytokines 
19
.  
Regulatory macrophages  
Hypothalamic pituitary-adrenal (HPA) axis releases glucocorticoids to inhibit the 
action of macrophages in the host. They interrupt the transcription of pro-inflammatory 
cytokines. TLR ligand signals production of IL-10 and downregulates production of IL-
12. This ratio of the two interleukins is an essential step in regulation. Other mechanisms 
to generate regulatory macrophages involve activation of MAPK and ERK 
16, 17
. 
EXTRAVASATION IN CASE OF ENDOTHELIAL INFLAMMATION 
In case of endothelial dysfunction, macrophages circulating in the blood 
extravasate from the endothelial cell barrier in response to the stimulus 
11-13
. The 
endothelial cells increase the production of E and P-selectins as well as pro-
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inflammatory cytokines like IL-1 or TNF-α which signals the macrophages to the port of 
inflammation 
11-14, 23
.  
ROLE OF REDOX MOLECULES IN INFLAMMATION 
Redox molecules include nitric oxide (NO)/ reactive nitric oxide synthase (RNS) 
and Reactive oxygen species (ROS). They serve as immune-toxins as well as immune-
modulator; they are capable of eradication of the pathogen and initiate an 
immunosuppression by restoring the tissue balance. They mediate a series of 
downstream signals pathways triggering diverse action against the pathogen 
21, 24, 25
. 
Reactive oxygen species comprise of singlet oxygen ions, hydrogen peroxide, 
hydroxyl ions and superoxide anions, generated by partial reduction of dioxygen in the 
mitochondrial oxidation pathway. These ROS are capable of oxidizing biological 
macromolecules 
25, 26
. The inducible nitric oxide synthase mediates the production of 
NO. There are three types on nitric oxide synthases- eNOS, nNOS and iNOS. iNOS is 
the one which is associated with the immune system and is produced from nM levels to 
uM levels. NO and NO2 are lyophilic in nature, then permitting it to migrate across. 
Despite of being crucial for, homeostasis ROS/NO are capable of causing oxidative 
stresses, lipid peroxidation, oxidize nucleic acids, protein modification and increased 
levels of free radicals in the host tissue 
26
. 
The presence of reactive oxygen species (ROS) in tissues was first proposed by 
Gerschman, Gilbert and co-workers as early as 1954. They discovered the toxic 
mechanism of oxygen in presence of increased partial pressure 
27
. Subsequent discovery 
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of superoxide dismutase lead to the postulation that ROS has a phagocytic action 
justifying their action to prevent oxidative stresses 
25, 26
.  
ROS is produced via two mechanisms in an intact cell- enzymatically and non-
enzymatically. Non-enzymatic reactions occur when foreign substances or endogenous 
metabolites like by-products of mitochondrial respiratory chains are auto-oxidized. On 
the other hand, enzymatic reactions are controlled and are known to promote signaling 
pathways within the cells 
24
. Primary sources of ROS include mitochondria and NADPH 
oxidase. NADPH oxidase (NOX) is a multi-protein present in the plasma membrane. A 
small G-protein initiates activation of NOX in presence of external stimuli like bacterial 
lipopolysaccharide (LPS) or various proinflammatory cytokines 
24
. After stimulation 
LPS, LPS binds to a Toll Like Receptor-4 (TLR-4), specific for LPS and induces ROS 
via mitochondria and NOX which leads to expression of IFN- β which promote iNOS 
and further induce NO production and also mediate iNOS via MAPK pathway 
21
. 
APPROACHES UTILIZED TO QUANTIFY ANTIOXIDANT CONTENTS OF 
POLYPHENOLS 
Numerous approaches have been employed to quantify the antioxidant content of 
fruits and vegetables. Frequently, utilized techniques for measuring the total phenolic 
compounds are DPPH, ABTS free radical decolorization assay, FRAP (ferric reducing 
antioxidant power assay) and Folin-Ciocalteau reaction.  
Different motley tests have illustrated results for total phenolic content 
28
 The 
following table is a summary of acerola content reported in the literature. 
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Table 1. Phenolic content in acerola reported 
Test employed Fresh acerola sample Lyophilized sample 
Folin ciocalteau (mg GAE/100 g) 1055.9 ±46.5 900 ±54.6 
ABTS (mg/100 g) 1315.0±25.3 1783.4±15.0 
DPPH ( EC50 mg/100 g) 838.8±0.4 795.0±6.8 
FRAP (mg/100 g) 495.1±12.3 491.3±7.2 
(Adopted from
28
)  
Concentrate of acerola are endorsed as potent anti-tumor which attenuates NKK 
formation which leads to suppression of development of lung tumor. Extracts can be 
used as new candidate for multidrug resistance by inhibiting the action of p-glycoprotein 
and antibacterial agent 
29
. It can be used as dietary supplements to increase the dermal 
density of skin and treating cutaneous aging 
30
. Apparently in a study juice from acerola 
was recommended as substitute for orange juice to infants  
31
.  
ACEROLA AS A SOURCE OF ANTI-INFLAMMATORY COMPOUNDS 
Acerola, is associated to genus Malpighigia, and in scientific taxonomy is called 
Malpighia emarginata D.C. It’s belongs to an evergreen small tree or a shrub. It is a 
drupaceous round fruit with thin epicarp which turns green to yellow to bright red after 
ripening. It is habituated to tropical or subtropical conditions, and requires fertile soil 
composed of clay plus sand which can hold humidity longer. It is endemic to Southern 
Texas, Mexico, Central and South America including Brazil and Caribbean. It is even 
cultivated in few areas of Asia like India, but currently Brazil is the largest grower of 
acerola 
32, 33
. It was conventionally called as West Indian Cherry, Haiti or Barbados 
cherry and is commercially utilized as juice, marmalade, gelatin, ice creams, frozen 
concentrate, jelly, gums, nutraceutical, liquor and yoghurt 
32, 34
.   
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Mature acerolas are extremely fragile and perishable with a shelf life of 2-3 days. 
After cultivation the cherries are hand-picked, early morning to avoid transpiration and 
maintain its quality attributes. Optimal storage temperature lies between 7-8
o
C 
33
. 
Phenolic compounds in acerola vary according to its maturity level and growth 
conditions. It has been exhibited that with changing conditions of maturity, phenolic 
content also varied 
35
. Composition of the fruit depends on various factors including 
climatic, culture treatment, location of the farms, utilization of pesticides, level of 
maturity, processing and storage 
33, 35
. The amount of ascorbic acid decreases during the 
ripening process, for example, from initial ranges  of 2.15 -  3.20 g/100 g to1.45 - 1.83 
g/100 g 
36
. 
 Acerola is a natural source of vitamin C with abundance of polyphenols and 
terpenoids. Previous reports have identified radical scavenging properties of acerola due 
to presence of anthocyanin and quercetins 
37
. Flavanoid- aceronidin has been isolated 
from green acerola has exhibited higher DPPH activity as compared to α-tocopherol 38.  
OBJECTIVES 
In this study, genotypes of acerola are screened for anti-inflammatory effects and 
to elucidate its putative mechanism using a mammalian cell model. The aim is to 
identify which genotype has a selective inhibitory action against COX-1 and COX-2.  
HYPOTHESIS 
Aspirin is a potent NSAID target which has an inhibitory action against COX-2 
and COX-1. We hypothesized that the extracts of different genotypes used for this 
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investigation have a COX inhibitory action like aspirin or a selective action like that of 
ibuprofen. Selective COX-2 inhibitors are a subject of interest in strategies to mitigate 
diseases such chronic inflammation and cancer and overcome limitations of NSAIDs. 
The aim is to endorse acerola as a natural NSAID.  
Specific objective 1: To determine an extraction procedure and identify the 
compounds present in each genotype of acerola. 
Chapter II deals with evaluation of chemical compounds present in acerola and 
which solvent should be employed to extract phytochemicals from the lyophilized 
acerola samples. Extracts were dissolved in methanol and were analyzed using TLC and 
LCMS. Different peaks depicting different masses at different retention time were 
identified using literature survey. 
Specific objective 2: To differentiate between different extraction processes using 
biological assays and determine selectivity of genotypes in COX assay kit. 
In chapter III, deals with comparing the effects on ROS, NO and mitochondrial 
activity on the basis of the different compounds present within each genotype. 
Furthermore acerola fractions were tested for their inhibitory action against COX-2 and 
some genotypes were selected for their selective action against COX-1. 
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CHAPTER II 
PHYTOCHEMICAL ANALYSIS OF ACEROLA LEAVES AND 
FRUIT GENOTYPES 
SYNOPSIS 
For this investigation two approaches were used. First, a qualitative analysis was 
performed using thin layer chromatography (TLC) and second, the identification of the 
various phytochemicals was performed using liquid chromatography-mass spectrometry 
(LC-MS). Isolation and identification of different components existent in a plant is an 
essential step in elucidating the mechanism of action in biological systems. 
TLC is mainly a qualitative analysis that determines the type of compounds 
present in an extract and gives insight of the possible amounts present. This test was 
executed to select the extraction procedure for biological assays. TLC results showed 
presence of high levels of terpenoids in the methanolic samples as compared to 
methanol/acetone/water. Isolation using methanol/acetone/water had negligible amounts 
of terpenoids. Polyphenols subsisting in each genotype was identified using LCMS.  
Nine out of thirteen peaks in distinct leaf genotypes were identified in the mass 
spectra at negative ionization mode at specific retention time. Likewise nine out of 
eleven peaks were identified in fruit fractions using positive ionization mode. These 
different flavanoids have hitherto ascertained their antioxidant activities in literature.  
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INTRODUCTION 
Acerola has been studied for the presence of high amounts of vitamin C content 
31, 34
 while other studies have reported presence of other phytochemicals including 
flavonoids 
28, 31, 34
.  
Anthocyanins are the most ubiquitously present polyphenol imparting red, violet 
color to the fruit belongs to class of flavonoids which are composed of six membered 
rings. The bioactivity of anthocyanin is based on the structure and function relationships 
and on the side chain 
39
. According to USDA database (2011) acerola has 15.71 mg/100 
g edible portion and 6.84 mg/100 g edible portion of cyanidin and pelargonidin 
respectively; and has 1.05 mg/100g of kaempferol with 4.74 mg/100g of quercetins 
40
. 
Functional characterization of green and ripe acerola have revealed them  to be 
an abundant source of anthocyanin, carotenoids, flavanol, benzopyrone, polyphenolic 
acid and aceronidin, whereas leaves have been reported to have high flavanol, 
phytosterol, triterpenes and sesquiterpenes 
38, 41, 42
.   
In a human intervention, comparing a synthetic ascorbic acid juice versus acerola 
juice, bioavailability of ascorbic acid from acerola was higher than the synthetic one. 
The investigation suggested that prominence of cyanidin-3-aO-rhamnoside and 
pelargonidin-3-a-O-rhamnoside present in the acerola juice enhanced the absorption of 
ascorbic acid into plasma and reduced its excretion through urine  
43
. 
 In another study, analyzing the effects of acerola juice on body fat mass., mice 
were fed with cafeterian diet (Mortadella, marshmallow, cheese chips, chocolate wafer, 
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water and Guaraná soft drink etc.) supplemented with water (for control), acerola juice 
(produced industrially or from ripe fruit, or immature acerola) and synthetic vitamin C. 
The results confirmed that a diet supplemented with acerola juice reduced the 
inflammatory proteins (TNF-α) and increased lipolysis in mice fed a cafeteria diet 44. 
The study of therapeutics from antioxidant derived from phytochemicals has 
been an area of interest for decades. These antioxidants participate in pathogenesis of 
coronary heart diseases, diabetes and cancer 
8
. These secondary metabolites are non-
essential metabolites utilized in the defense mechanism against the ultraviolet radiation 
and pathogenic attacks on the plants. Among the range of antioxidants present in plants, 
phenolic compounds are the largest group including flavonoids, anthocyanins, 
hydroxycinnamic acids, hydroxybenzoic acids and catechins 
8
.  
In the present study, for detection of the polyphenols present in a range of 
genotypes of acerola we used the LC-MS technique as well a different solvents for the 
extraction procedure. Liquid chromatography mass spectroscopy (LCMS) is a reliable 
approach utilized in detection and separation of chemicals on the basis of the molecular 
mass from a mixture of compounds. It is a powerful system used for identification and 
isolation in pharmaceutical, drug and food industries. LCMS separates components on 
the basis of their molecular masses. Being highly sensitive this technique has been used 
for identification of natural compounds from a plant derived mixture 
45
. 
This study begins by employing three different solvents for extraction of 
phytochemicals including methanol, methanol/acetone and methanol/acetone/water 
under the hypothesis that different solvent mixtures will extract different group of 
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compounds based on polarity. Methanol is able to extract maximum amount of polar/non 
polar phytochemicals while a mixture of methanol and acetone (1:1) could favor the 
extraction of more non polar compounds compared to only methanol. The third solvent 
mixture methanol/acetone/water potentially could extract high content of polar 
compounds compared to methanol alone. In the present study we evaluated the use of 
different solvents for the extraction of bioactive compounds from acerola, determined 
the presence of terpenoids using TLC and identified the presence of polyphenols by 
LCMS. The selection of the appropriate solvents and compound identification in this 
chapter 2 would be critical for the studies of anti-inflammatory properties in chapter 3. 
MATERIAL AND METHODS 
Materials 
Genotypes of Acerola leaf and ripe fruits (BRS-186, BRS-235, BRS-236, BRS-
237, BRS-238, BRS-366) were brought from EMBRAPA Brazil. The chemicals used 
were purchased from VWR.  
Extraction of the acerola samples 
Extraction was performed using two methods: 100% methanol and extractions 
with methanol/acetone/ water (5:4:1). Around 100 mg of the raw lyophilized (leaf and 
fruit) samples were dissolved in 1000 µl of one of the above solvents. The mixture was 
vortexed followed by sonication for 40 mins. Then the mixture was stirred for overnight 
at a 4°C. After that the mixture was centrifuged for 10 min, at  >3000 rpm (The Drucker 
Company, Port Matilda, PA) and the supernatant was filtered using 0.2 μm syringe 
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filters (VWR, Radnor, PA, USA) in pre-weighed tubes. Leaves extracts were 
additionally washed with 1000 µl hexane and the supernatant of the biphasic layer 
formed was separated using a separating funnel. Then the supernatants were 
concentrated in a vacuum centrifuge (LABCONCO) at 45°C to dryness. Then the 
extracts were re-suspended in methanol prior to LC-MS analysis or DMSO for 
biological assays.  
Evaluation of terpenoids using Thin Layer Chromatography 
100 mg of raw lyophilized BRS-238 leaf sample was dissolved in 1000 µl 
methanol, methanol/ acetone (1:1) and methanol/acetone/water (5:4:1) separately. They 
were vortexed and centrifuged for 10 min and later stirred in the cold room for 
overnight. After incubation, they were centrifuged and the supernatant was filtered using 
0.22um filter; subsequently collected in a pre-weighed tubes. The supernatants were 
washed with 1000 µl of hexane and the biphasic layers formed was separated using a 
separating funnel and both the layers were collected in separate pre-weighed tubes. The 
residues from each solvent were washed using 1000 µl chloroform and the supernatant 
was collected in the pre-weighed tubes after being stirred and centrifuged for 30 min. 
Small amount of all the various supernatants were spotted on the silica plate. The TLC 
plate was run using all the various supernatants in a mobile phase of 10% methanol and 
DCM (dichloromethane). The run was then visualized using UV and 
anisaldehyde/sulfuric acid spray reagent as shown in Figure 2.1. 
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HPLC/MS methodology 
Identification of phenolics from the acerola leaf genotypes by LC-MS analysis 
The system used was a Surveyor (Thermo Scientific, USA) coupled to Surveyor 
DAD. The eluents were composed of acetonitrile/methanol (1:1), formic acid (0.5:99.5, 
v/v) (phase A) and formic acid–water (0.5:99.5, v/v) (phase B). 10 µl of the sample were 
injected applying an elution conditions of: 0-2 min, 2% A, 98% B; 3-5 min, 5%A, 95% 
B, 5-30 min, 20% A, 80% B; 30-72min, 35% A, 65% B; 72-83 min, 100% A, 0% B; 83-
85 min was held isocratic, 100% A; 87-90min 2% A, 98% at the starting condition. The 
chromatograms were monitored at 330, 280, 210 nm; and complete spectral data were 
recorded between the range of 200–600 nm. A reversed-phase Phenomenex (Torrance, 
USA) Luna C18 column (150mm×4.6mm i.d. and particle size 3µm) with a Waters 
Nova-Pack C18 guard column (10mm×3.9mm i.d, 4 µm) was used and a flow of 200 
µl/min from the DAD eluent was directed to the ESI interface using a flow-splitter. 
Nitrogen was used as desolvation gas, at 275
◦
C and a flow rate of 60 L/h, and no cone 
gas was used. Mass spectra were obtained on a MS Finnigan LCQ Deca XP Max,  Ion 
trap mass spectrometer coupled at the exit of the diode array detector and equipped with 
a Z-spray ESI source, and run by Xcalibur version 1.3 software (Thermofinnigan-
Surveyor, San José, USA). A potential of 1.5 kV was used on the capillary for negative 
ion mode. The source block temperature was held at 250 
◦
C.  
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Identification of phenolics from the acerola fruits genotypes by LC-MS analysis 
100mg each of lyophilized ripe fruits genotypes was dissolved in a 1000 µl of 
MeOH separately and stirred for 24 h at 4
◦
C. The extracts were centrifuged and then 
filtered. The filtrate was concentrated until all the volatile solvent was evaporated to 
dryness. The above samples were re-dissolved in MeOH this extract was used to analyze 
the profiling of the compounds present in the ripe fruits genotypes. 
Individual compounds were identified on the basis of retention time, UV spectra, 
and their mass-to-charge ratio using LC-MS/MS. Chromatographic separations were 
performed on a LCQ Deca XP Max MS
n
 system (Thermo Finnigan, San Jose, CA, USA) 
equipped with an autosampler, a Surveyor 2000 quaternary pump, and a Surveyor UV 
2000 PDA detector using a Hydro-RP18 Phase (150 mm x 4.6 mm x 3 mm, 
Phenomenex, Torrance, CA, USA, particle Sizes (4 µm) and pore size of 100 Å) and a 
guard column of the same chemistry. 10 µl of the sample was injected and elution 
gradients were performed with solvent A consisting of acetonitrile/methanol (1:1 
containing 0.5% formic acid) and solvent B: water containing 0.5% formic acid. The 
elution gradients were performed with acetonitrile/methanol (1:1), formic acid (0.5:99.5, 
v/v) (phase A) and formic acid–water (0.5:99.5, v/v) (phase B). The applied elution 
conditions were: 0-2 min, 2% A, 98% B; 3-5 min, 5%A, 95% B, 5-30 min, 20% A, 80% 
B; 30-72min, 35% A, 65% B; 72-83 min, 100% A, 0% B; 83-85 min was held isocratic, 
100% A; 87-90min 2% A, 98% to the starting condition. The chromatograms were 
monitored at 330, 280, 210 nm; and complete spectral data were recorded in the range 
200–600 nm.  Nitrogen was used as desolvation gas, at 275◦C and a flow rate of 60 l/h, 
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and He gas was used as damping gas. Mass spectra were obtained on a MS Finnigan 
LCQ Deca XP Max,  Ion trap mass spectrometer coupled at the exit of the diode array 
detector and equipped with a Z-spray ESI source, and run by Xcalibur version 1.3 
software (Thermofinnigan-Surveyor, San José, USA). A potential of 6.8 V was used on 
the capillary for positive ion mode. Spray voltage of 4.57 kV and the source block 
temperature was held at 255
°
C. 
RESULTS AND DISCUSSION 
Evaluation of terpenoids using Thin Layer Chromatography 
In thin layer chromatography the mobile phase (generally liquid or gas) traverses 
over the stationary phase (solid or liquid) displacing different component present in it. 
The chemicals present in the stationary phase travels according to its speed on the 
mobile phase. Basically this test estimates the quantity of different components present 
in the mixture. In this study, strong intensity steroid band were detected in the 
supernatants of MeOH and MeOH/Ac extracted fractions. However, very weak intensity 
band was observed in extracts of MeOH/Acetone/H2O. Hexane did not remove any 
steroids. The residues were treated with chloroform to detect presence of any terpenoids, 
however no bands were observed. Terpenoids and polyphenols were isolated using the 
different solvents. MeOH/Acetone/H2O had negligible amounts of terpenoids assuming 
it to potentially have higher polyphenols whereas MeOH extracts had terpenenes as well 
(Table 2.1). 
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During the extraction procedure the pH of acerola was measured using a pH 
indicator strip giving pH values between 3 – 4 which matches with previous studies of 
reported pH values of 3.7 
46
. This confirms that the stability of anthocyanins were not 
affected during the extraction procedure in the present.  
The fractions from the two extracts were used to quantify the biological 
activities, discussed in chapter III. 
Identification of phenolics from the acerola leaf genotypes by LC-MS analysis 
The HPLC-DAD chromatogram of the acerola leaves at 330, 280, 210 nm was 
carried out using liquid-chromatography-mass-spectrometry (LC-MS) as shown in 
Figure 1. The fragmentation patterns of MS and MS
2
, along with potential compounds 
identified are shown in Table 2.2.  
The derivatives of flavonoids were detected and identification was achieved by 
comparison of MS
2
 fragmentation pattern, UV spectra (nm) and retention time (RT) with 
data reported in the literature. The MS
2 
data mining process begins by identifying the 
fragments of aglycone flavonoid is recognized to determine the backbone of each 
compound; thus quercetin ([M-H] m/z 301 Da), isorhamnetin ([M-H] m/z 315 Da) and 
kaempferol ([M-H] m/z 285 Da) were identified. Further step involves determining the 
number and type of sugar units attached to each flavonoid skeleton. 
The retention times, molecular weight (MS) and MS
2
 data of the phenolic 
compounds detected in the extracts are listed in Table 2.2. The compounds were 
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identified according to their fragmentation data and UV absorption and their structures 
are shown in Figure 2.2. 
The MS
2
 analysis of the precursor ions from peaks 1, 2, 4, 5 and 7 yielded major 
MS
2
 fragment at m/z 285, thus, these compounds were tentatively identified as 
kaempferol O-glycosides (Table 2.2). Compound 1 gave [M-H]
- 
m/z 711; yielding 
fragments at m/z 579 [M-H-132]
-
 and m/z 285
 
[M-H-132-146-132]
-
. According to 
these fragments, two sugar units, such a hexose (162 Da), and two pentose (132 Da) are 
attached to a kaempferol molecule. In order to confirm the structure, the compound 1 
was isolated for NMR studies. Hence the structure was confirmed on the basis of 2D 
NMR and the new molecule was assigned as kaempferol 3-O-β-D-[- arabinopyranosyl-
(1'''→2'')-O-α-L-apiose-(1''''→5'')-O-β-Dglucopyranoside 47. 
The compound 2, precursor ion at m/z 725 [(M-H)-]
-
, yielded fragments at m/z 
579 [(M-H)-146]
-
, m/z 598 [(M-H)-132]
-
 and m/z 285 [(M-H)-146-132-162]
-
. According 
to these fragments, three different sugar units, such a hexose (162 Da), a deoxyhexose 
(146 Da) and a pentose (132 Da) are attached to a kaempferol molecule. Thus compound 
2 was identified as kaempferol 3-O-robinobioside-7-alpha-L-arabinofuranoside.  The 
fragmentation pattern of compound 3, at m/z 755 [(M-H)]
-
, yielded ions at m/z 623 [(M-
H)-132]
-
, m/z 315 [(M-H)-146-162]
-
 . The tri-glycoside 3 was identified as quercetin 3'-
methoxyquercetin-7-O-α-L-rhamnopyranosyl-3-O-α-arabinofuranosyl-(1→6)-β-D-
glucopyranoside (3) and fragmentation of this compound ions at m/z 623 [(M-H)-132]
-
 
suggests that pentose is directly attached to the ring and the similar compound from the 
aerial parts of Atriplex halimus L. collected from Sardinia has pentose at position 7 and 
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rutinoside at position 3, precursor ion at m/z 593 [(M-H)]
-
, generated fragments at m/z 
490 [(M-H)-146+41]
-
 and m/z 301 [(M-H)-146-162]
-
. Hence compound 3 was identified 
as 3'-methoxyquercetin-7-O-α-L-rhamnopyranosyl-3-O-α-arabinofuranosyl-(1→6)-β-D-
glucopyranoside 
48
. Compound 4 and 5 gave [M-H]
-
 m/z at 579 and the MS
2
 analysis of  
precursor ion at m/z 579,  yielded the fragments at m/z 285 [(M-H)-162]
-
. The compound 
4 and 5 was identified as kaempferol O-glycosides isomers, according to the 
fragmentation pattern in the literature 
49
. 
The compound 7 with the precursor ion at m/z 593 [(M-H]
-
 , showed similar 
fragments at m/z 285 [(M-H)-146-162]
-
 and m/z 257.18 [(M-H)-146-162-28]
-
, then these 
di-glycosides are isomers. Hence the compound 7 was identified as kaempferol 7-O-
neohesperidoside, previously characterized by LC-ESI-MS analysis in cocoa 
(Theobroma cacao) 
50
. This is the first report of kaempferol 7-O-neohesperidoside in 
Malpighia emarginata samples. 
Compound 8, precursor ion at m/z 623 [(M-H)]
-
, yielded fragments detected at 
m/z 461 [(M-H)-162]
-
and at m/z 315 [(M-H)-146-162]
-
, showing that this compound is a 
di-glycoside. The fragmentation pattern of compound 8 allowed identification of 
isorhamnetin 3-O-rutinoside (narcissin), according to the data obtained by 
51
.  
Compound 9, 10, 12 and 13 gave precursor ion m/z [M-H]
-
 917, 931, 857 and 871 
respectively and yielded MS
2
 fragments 711, 693 for m/z 917 and 739, 725, 605, 298 for 
m/z 931 and 693 for m/z 857 and 751, 725, 707, 441 for m/z 871. These fragments were 
not reported in the literature and their structures need to be confirmed by NMR. The 
precursor ion at m/z 785 gave MS
2
 fragments at m/z 593 and m/z 313, which is 
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characteristic of hexose isomer and hence the compound was tentatively identified as 
digalloyl-HHDP-glucose 
52
. 
Identification of phenolics from the acerola fruit genotypes by LC-MS analysis 
Peaks at R.T 26.5 and 27.3  had the molecular ion ([M+H]
+
) at m/z 434 and 418 
respectively, and by MS/MS experiment a major fragment at m/z 270 and m/z 287 
respectively and was assigned to cyanidin-3-rhamnoside and pelargonidin 3-rhamnoside 
respectively
53
. The exact mass of the Peak at  retention time (R.T.) of 28.4 could not be 
identified clearly but it gave a major MS/MS fragment ion at 301 which suggested a 
peonidin derivative, peaks at R.T 31.0, 31.7 and 44.5 gave molecular ions at m/z 596, 
451 and 464 respectively, on MS fragmentation m/z 596 gave fragments at m/z 449 and 
287 and was assigned to cyanidin 3-rutinoside, m/z 451 gave mass fragments at m/z 303 
and m/z 316 and was assigned to peonidin-3-xylopyranoside, m/z 464 gave a major 
fragment ion at m/z 301 suggesting again a peonidin derivative and was assigned to 
peonidin-3-rutinoside
54
. Peaks at R.T 53.2 and 58.8 also gave fragmentation ion at m/z 
301 and m/z 316 suggesting again a peonidin derivative and hence the peaks were 
identified as peonidin-3-rutinoside and peonidin-3-O-diglucoside respectively. Peaks at 
R.T 50.88 and 58.8 gave fragment ions at m/z 303 and m/z 339, m/z 423 and m/z 365 
respectively; however they could not be identified as shown in Table 2.3 and figure 2.3. 
CONCLUSIONS 
From the above experiments LCMS has revealed that leaves and fruits comprise 
of derivatives from flavonoids and anthocyanins respectively. It was for the first time 
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these genotypes were examined. Ripe fruits are red making them ample in anthocyanin. 
Moreover the derivatives identified were cross checked from the literature. TLC results 
validate presence of terpenes in methanol rather than methanol/acetone/water. It was 
hypothesized that MeOH/Acetone/H2O had negligible amounts of terpenoids concluding 
it to be rich in polyphenols whereas MeOH extracts had presence of both phenolic as 
well as terpenoids  
Individual compounds are known to contribute to various biological activities 
and have been linked with protection as antiallergic, antiinflammatory, antiviral, 
antiproliferative, and anticarcinogenic activities 
39, 55
.Generally flavonoids consumed are 
flavonols, flavanones, and isoflavones. A large spectrum of beneficial pharmacological 
properties have been studied for flavones 
39, 55
. Anthocyanins, are recognized as a natural 
colorant and a substitute for synthetic colorants which toxic for human 
56
.  
Nine out of thirteen peaks identified in acerola leaf were quercetin and 
kaempferol derivatives which have been reported previously in acerola. In case of fruits 
peonidin-3-xylopyranoside and peonidin 3-rutinoside has been recorded for the first time 
in acerola. Derivatives of peonidin have been analyzed to be down-regulating metastasis 
57
. We conclude that there is a broad range of polyphenols and terpenoids existent in leaf 
and fruit samples give acerola the potential to exert anti-inflammatory properties which 
is further explored in chapter 3. 
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CHAPTER III 
ANTI-INFLAMMATORY PROPERTIES OF ACEROLA LEAVES 
AND FRUIT GENOTYPES 
SYNOPSIS 
This chapter comprises of the biological aspect of acerola in their anti-
inflammatory properties. Extracts of different leaf and ripe fruit samples were selected 
on the basis of the TLC work from chapter 2. It was hypothesized that due to presence of 
a terpenoids/polyphenols mixture, methanolic extracts have more biological activity as 
compared to Me/Acetone/water which only contains polyphenols. A decrease in ROS 
levels and partial decrease in NO production were observed in methanolic extracts 
compared to Me/Acetone/water extracts. This effect was evident for leaf methanolic 
extracts which contained a mixture of terpenoids/polyphenols very likely responsible for 
the effect.  
Methanolic extracts were further analyzed to study the action on COX enzymatic 
expression. Almost all genotypes exerted inhibition against COX-2 and COX-1 activity. 
From all samples studied, BRS-238 fruit had a selective action against COX-2 and 
COX-1. Consequently, this genotype is likely to have a putative mechanism similar to 
that of known drugs like celecoxib and rofecoxib. NSAIDs are known to exhibit 
analgesic, antipyretic, anticarcinogenic, anti-inflammatory properties. The ultimate goal 
is to propose acerola as a functional fruit with a potent NSAID like property, with the 
24 
advantage of being a natural occurring selective inhibitor of COX-2 which can overcome 
the limitations of commercial drugs like aspirin. 
INTRODUCTION 
Humans differ in their response to drugs for multiple reasons but particularly as a 
result of inter-individual genetic differences in drug absorption, distribution, metabolism 
and excretion. All of these are potential sources of pharmacokinetic variability and can 
have significant effects on treatment outcomes. For example, the chemo-preventive 
potential of NSAIDs (Non-Steroidal Anti-inflammatory Drug) could be enhanced, and 
more selectively targeted, by taking into account of such relevant pharmacogenetic 
differences. 
During the succession of inflammation, transcription factors like JNK (c-Jun N-
terminal kinase), NF-ĸB (Nuclear factor ĸB) and MAPK (Mitogen-activated protein 
kinase) are activated and they eventually transcribe pro-inflammatory and anti-
inflammatory cytokines which are indispensable for signaling pathway 
16, 18
. NF-ĸB is an
omnipresent redox transcription factor involved in regulation of various genes associated 
with immune responses against pathogens. It is localized in the cytoplasm and is 
translocated in the nucleus in presence of stimuli after being phosphorylated 
16, 18, 26
.
Redox mechanism of NF-ĸB and inflammation 
The pathway is mediated via phosphorylation and subsequent ubiquitination IĸB. 
IĸB and NF- ĸB are present in the cytoplasm in basal levels in an unstressed cell. In 
macrophage, the LPS, binds to TLR-4 (Toll like receptor-4), a pathogen-associated 
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molecular pattern (PAMP) and induce degradation of IĸB leading it to translocation of 
NF-ĸB to the nucleus and initiating a transcription and production of gene expressions of 
TNFα, COX-2 and iNOS, which are mediated  by LPS/TLR4 signaling pathway 58. The 
TLR4 signaling is also mediated by mitogen-activated protein kinase (MAPK) signaling 
cascades 
59
. Briefly, TGFβ-activated kinase 1 (TAK1) induces the extracellular signal-
regulated kinase (ERK) pathways via IκB kinase (IKK) 60, 61. The MAPKs triggers an 
interferon β signaling pathway and induces iNOS expression via activating the STAT-1. 
iNOS expressions amplifies production of NO after 6 h via IFN-β 62. 
Antioxidant compounds are compounds that quench free radicals by donating 
electrons. There are two types of antioxidants, first which exist endogenously like 
glutathione peroxidase, catalases and superoxide dismutase; and second which needs to 
be supplemented from outside sources are exogenous 
63
. Plethora of reports have 
elucidated that plant derived phytochemicals have antioxidant capacity. There are 
several mechanisms targeted by phytochemicals in in-vivo systems. For example: 
flavanoids, commonly consumed polyphenolic compound are known to exhibit anti-
inflammatory effects in LPS stimulated macrophages by inhibiting NF-ĸB and further 
expression of iNOS in a dose dependent manner. Quercetin inhibits STAT-1 
transcription factor along with iNOS expression 
64, 65
. Curcumin, commonly found in 
rhizhomes have inhibited proliferation and ROS in TPA induced mouse epidermal cells 
66
. 
Different array of prostaglandins (PG) are produced by each cell type in response 
to inflammation, wound healing, nerve growth and development, blood clotting and 
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ovulation. The production of PG in response to external stimuli is mediated by the 
biosynthesis of eicosanoids. Briefly, diacyglycerol from the membrane undergoes 
hydrolysis to archiadonic acid which is a substrate for cyclooxygenases. Subsequent 
peroxidation of archiadonic acid promotes production of prostaglandins by 
cyclooxygenases 
67, 68
. NSAID drugs targets the cyclooxygenases which are the 
precursors of prostaglandins, consequently inhibiting inflammation. There are two 
isozymes of cyclooxygenases-COX-1 and COX-2. COX-1 is a precursor for 
thromboxane synthesis. NSAIDs like aspirin are known to bind to COX-1 irreversibly 
preventing platelet aggregation 
67, 69, 70
. This binding has its pros and cons. In terms of 
cardiovascular disease aspirin binding to COX-1 it is an important mediator to prevent 
thrombosis; however inhibition of COX-1 affects homeostasis and even disrupts renal 
functions. On the other hand COX-2 is induced in presence of inflammation or during 
cases of stresses. It is reported to be produced in high quantities in presence of fever and 
synovial tissues during osteoarthritis. COX-2 specific inhibitors like Celecoxib and 
ibuprofen have demonstrated to exert suppression of inflammation and overcome 
innumerous adverse effects associated with non-selective drugs like aspirin 
67-71
.  
This chapter aims at elucidating a putative acerola phytochemical responsible for 
the scavenging effect of ROS and partially suppression of NO levels and COX inhibitory 
activity. Thereby two solvent based extraction procedures were selected for this 
investigation. One set of extracts (MeOH/Acetone/H2O) were abundant in polyphenols 
whereas another set (MeOH) possessed a combination of terpenes and phenolics. A 
comparative analysis indicates that methanolic fruit and leaf fractions attest greater 
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biological effect, probably due to presence of both terpenes and phenolics. In addition, 
this chapter deals with COX inhibitory activity of acerola extracts where MeOH extracts 
inhibited COX-1/2 enzyme activity indicating it to have similar actions as commercial 
NSAIDs.     
MATERIALS AND METHODS 
Materials  
The following chemicals were used in the experiments: Lipopolysaccharide 
(LPS), 2′,7′-Dichlorofluorescin diacetate (DCFA), Griess reagent, Sodium nitrite 
solution, Dulbecco’s Modified Eagle’s Medium (DMEM)/low glucose, phenol red-free 
DMEM/low glucose, penicillin/streptomycin mixture, DMSO and Fetal Bovine Serum 
(FBS) were purchased from Sigma (St. Louis, MO). Glucose and sodium bicarbonate 
were purchased from Acros Organics (Fair Lawn, NJ) and sodium bicarbonate from 
Mallinckrodt Chemicals (Phillipsburg, NJ) respectively. The CellTiter 96® AQueous 
Non-Radioactive Cell Proliferation Assay kit was purchased from Promega (Madison, 
WI). The Macrophages RAW 264.7 (cell line TIB-71™) was acquired from the 
American Type Culture Collection (ATCC) (Manassas, VA). COX (human) Inhibitor 
Screen Assay kit was purchased from Cayman Chemical.  
Cell culture and drug treatment 
RAW 264.7 mouse macrophages were cultured in the DMEM-low glucose (pH 
7.2 – 7.4) supplemented with 4 g/l glucose, 3.7 g/l sodium bicarbonate, 10% fetal bovine 
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serum (FBS) and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin) in a 
humidified atmosphere with 5% CO2 at 37°C. They were passaged in every 2-3 days.  
Macrophages were plated at 0.5 ×10
5
 cells/well in a 96-well black and clear 
bottom plates (Costar, Cambridge, MA). The cells were incubated with the acerola 
extracts for 5 h and then cells were treated with 1 µg/ml LPS for 4 h or 19 h in this 
study. The extracts of genotypes were dissolved in 100% DMSO. For treatment of cells 
0.5% of DMSO dissolved samples were exposed in all experiments.   
Cell viability test 
The proliferation of viable cells was evaluated using 3-(4,5-dimethylthiazol-1)-5-
(3-carboxymeth-oxyphenyl)-2H-tetrazolium, CellTiter 96
®
AQueous One Solution 
according to the manufacturer’s manual (Promega, Madison, WI). Briefly, 0.5×105 cells 
were seeded in a 96-well plate (BD Biosciences, Franklin Lakes, NJ). Then cells were 
incubated for 24 h with growth media containing 400 µg/ml of acerola fruits and leaves 
extracts. Afterwards, cells were re-suspended with 100 µl of growth media 
supplemented with 20 µl CellTiter 96
®
AQueous One Solution and the plate was 
incubated for 2 h. The assay is known to detect the absorbance of formazan produced 
which could be measured at 490 nm.  
Cell viability was calculated using the following equation:  
Atreatment 490 nm/Acontrol 490 nm * 100 = % cell viability 
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Detection of extracellular nitric oxide and intracellular reactive oxygen species 
production 
Macrophages were plated 0.5×10
5
 cells/well in a 96-well black and clear bottom 
plates and cultured overnight. The cells were stimulated by LPS for 4 h and 19 h and 
treated with or without the 5 h-pre-treatment with 400 µg/ml acerola fractions. Finally, 
cells and medium was used for ROS and NO detections respectively. The extracts of 
genotypes were dissolved in 100% DMSO. For treatment of cells 0.5% of DMSO 
dissolved samples were exposed in all experiments.   
First, nitric oxide production was assessed after 19 h LPS treatment. The nitrite 
(NO2
−
) levels accumulate in the medium and can be determined using a colorimetric 
reaction with the Griess reagent. 50 µl of cell culture supernatants were mixed with an 
equal volume (50 µl) of Griess reagent. The readings were calculated against the 
standards between 0 to 100 µM sodium nitrite solutions. Subsequently, the absorbance 
was measured at 540 nm using a 96-well microplate reader (Synergy HT, Bio-Tek 
Instruments, Inc., Winooski, VT).  
Second, the intracellular ROS production was evaluated by measuring the 
fluorescence of 2′,7′-Dichlorofluorescin diacetate (DCFA). This non fluorescent probe 
permeates inside the cell membrane; ROS oxidizes the probe into fluorescent DCF. 
Briefly, after LPS stimulation for 4 h and 19 h, the cell culture medium was removed 
and subsequently cells were exposed to phenol red/FBS-free DMEM media containing 
10 µM DCFA for 30 min. Then the cells were washed twice with the phenol red/FBS-
free DMEM. Finally, fluorescence was read immediately at wavelengths of 485 nm for 
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excitation and 528 nm for emission using a 96-well microplate reader (Synergy HT, Bio-
Tek Instruments, Inc., Winooski, VT).    
LPS-induced mitochondrial activity using MTS   
Mitochondrial activity was evaluated in macrophages using the MTS assay kit 
(Promega, Madison, WI). Cells were seeded 0.5×10
5
 cells/well after a pretreated with/ 
without 400 µg/ml of acerola fruits and leaves extracts acerola fractions for 5 h, Raw 
264.7 were challenged with/without LPS for 19 h. The absorbance was measured using 
the manufacturer’s protocol as explained above. 
Evaluation of COX-1 and 2 binding nature of acerola fractions  
The experiment was performed using a ‘COX (human) Inhibitor Screen Assay’ 
kit (Cayman Chemical), which measures PGF2α. PGH2 is reduced by SnCl2 into PGF2α 
which is measured according to the manufacturer’s protocol. Briefly, 10 µl of 200 µg/ml 
of acerola fractions were diluted with 90 µl of reaction buffer (4 mg/ml mixture provided 
from the manufacturers which was dissolved in 10% DMSO). From their 10 µl of the 
samples, DMSO (negative control), DuP-697 (positive control) were mixed with heme, 
COX-1/2 (human recombinant) enzyme and reaction buffer. The tubes were incubated 
for 10 min at 37
O
C. Afterwards the reaction was initiated by addition of arachidonic acid 
for 2 min and later was terminated by 1 M HCl followed by addition of stannous 
chloride (SnCl2). The reaction tubes were diluted, 2000X using EIA buffer and plated 
into the 96 well plate according to the protocol. Then level of PGF2α produced was 
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measured using microplate reader (Synergy HT, Bio-Tek Instruments, Inc., Winooski, 
VT) 410 nm and the calculations were made against the standards. 
Statistical analysis 
The data were analyzed using one-way analysis of variance (ANOVA) and t-test, 
using the software JMP pro v11.0. Results are expressed as means ± standard errors 
(SE). Different letters show significant differences (P < 0.05). 
RESULTS AND DISCUSSION 
TLC results demonstrate that methanolic extracts are rich in terpenes and 
phenolics whereas MeOH/Acetone/H2O extracts lacked steroids so have greater phenolic 
content. For this study, a comparison is executed to illustrate the putative action of 
acerola. That is, which compounds are responsible for scavenging ROS and NO as well 
as their inhibitory effect against COX activity in RAW 264.7.  
Cytotoxicity of leaf and fruit extracts  
MTS assay results indicate that 400 µg/mL acerola leaf and fruit extracts did not 
show any cytotoxic effects on macrophage cells (Figure 3.1). An increase in 
mitochondrial activity is observed in acerola treated cells as compared to the non-treated 
cells which did not affect the overall results of the present study. 
Protection of acerola extracts against LPS-induced inflammation in Macrophages 
The measurement of ROS in the present study was done at two time intervals of 
4 and 19 h. According to a previous study the levels of LPS induced ROS are maintained 
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until 6 h, afterwards the levels of ROS induction in macrophages are partially mediated 
through nitric oxide. Therefore this investigation was divided into an early (before 6 h) 
ROS stage before NO induction and a late stage (after 6 h) after NO induction 
21, 72
. 
LPS challenged cells stimulates TLR mediated pathway. LPS binds to TLR4 and 
activates a ROS- NO mediated redox signaling 
16, 18
. ROS is induced from NADPH 
oxidase and mitochondria which initiates translocation of NF-ĸB into the nucleus after 
being phosphorylated. It then further leads to expression of iNOS and COX-2.   
In this investigation we illustrate the effects of various genotypes of acerola leaf 
and fruit fractions extracted from two different solvents in LPS-stimulated RAW 264.7 
macrophage cell lines to determine which group of phytochemical would most likely be 
involved in the ROS signaling. 
For methanol extracts all of the leaf samples exhibited scavenging effect after 4 
h (Figure 3.2 A.1) stimulation of LPS and the scavenging effect continued even after 19 
h (Figure 3.3 A.1). However there was a partial scavenging after 19 h which could be 
due to the extracts being depleted after the long term LPS stimulation. Accordingly, 
acerola methanolic leaf extracts had early ROS scavenging properties. On the other 
hand, forfruit samples, other than BRS 238 and 366 none of them showed scavenging 
effect after stimulation of LPS for 4 h (Figure 3.2 A.2), however, a remarkable decrease 
was exhibited by all genotypes after 19 h (Figure 3.3 A.2) of the LPS challenge. This 
would suggest different scavenging kinetics between leaf and fruit acerola 
phytochemicals mainly due to terpenoid/polyphenol mixtures. 
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For methanol/acetone/water leaf extracts, these could not suppress ROS after 19 
h stimulation (Figure 3.3 B), however, BRS-236 and BRS 366 leaf samples scavenged 
ROS levels at 4 h (Figure 3.2 B). On the other hand, despite only BRS- 366 fruit extract 
reduced LPS challenged cells after 4 h (Figure 3.2B), all genotypes exhibited partial 
decrement after 19 h stimulation of LPS (Figure 3.3B). Once again, these results would 
suggest different scavenging kinetics between leaf and fruit acerola phytochemicals, 
which in this case is associated solely to the polyphenols present in the samples. 
In case of methanol extracts all genotypes of leaf samples displayed partial 
suppression of NO levels after 19, however, no suppression was observed as far is fruits 
are concerned (Figure 3.4 A). 
A weak suppression effect was observed in methanol/acetone/water fruit extract- 
BRS 236 and BRS238 (Figure 3.4 B) 
LPS stimulates iNOS gene which promotes production of nitric oxide (NO) after 
6 h and it reaches its maximal levels in around 8 h 
21, 64
. Enzymatic reaction by nitric 
oxide synthases on L-arginine produces nitric oxide 
24
. Generally iNOS is responsible 
for prolonged production of nitric oxide levels. LPS stimulates ROS from various 
sources which activate transcription of NF-ĸB, AP-1 and subsequently other cytokines 
like TNF-α. For methanolic as well as MeOH/Acetone/water extracts nitric oxide levels 
were partially suppressed or mostly unaffected. In the case of acerola leaf extracts to the 
partial suppression of levels of ROS at 4 h, was responsible for the partially suppression 
in the production of nitric oxide levels. For all other samples the levels of ROS 
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suppression at 4 h was not enough to affect transcription factors and iNOS gene 
expression so as to affect NO production. .  
Terpenes have been known to exhibit immunomodulatory, antiallergic and 
immunosuppressant actions 
73-76
. Phenolic compounds also have scavenged ROS and 
nitric oxide 
1, 35, 37, 39
. It is clear that the extent to which each phytochemical may display 
an effect determines the response. In this investigation two solvents were used assuming 
that each extraction procedure potentially isolated and enriched extracts into mixtures of 
terpenes/polyphenols and solely polyphenols. For instance methanolic compounds 
demonstrated to have high quantity of terpenes as compared to methanol/acetone/ water 
as shown in the TLC work in Chapter 2. One hypothesis could be that terpenes displayed 
higher activity or a synergistic effect with polyphenols when mixed in the methanolic 
extracts as compared to methanolic/acetone/water which contained only polyphenols.    
LPS-induced mitochondrial activity using MTS  
Tetrazolium salt in MTS is bioreduced to a blue colored compound formazan by 
NADH or NADPH. It is a reflection of the glycolysis pathway and the Kreb’s cycle 
activity inside the cells which are main sources of NADH or NADPH. In presence of 
LPS macrophages undergo increased aerobic glycolysis where glucose is rapidly 
consumed and is converted into lactate while mitochondrial respiration activity 
decreases with a simultaneous increase in ROS production due to an increase in electron 
leaks from the mitochondrial electron transport system which react with water to 
produce free radicals. Such effect has been termed as Warburg effect 
77-79
. This 
phenomenon is commonly witnessed in tumor cells, however inflammated cells also 
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switch to aerobic glycolysis in presence of oxygen leading to upregulation of hypoxia 
factor-1α (HIF-1α) and PKM-2.  Both (HIF-1α) and PKM-2 seem to be upregulated by 
transcription factor NF-ĸb and thus are ROS dependent. Protein kinase (PKM-2) is an 
essential enzyme in glycolysis which catalyzes phosphophenol pyruvate to pyruvate 
78
.  
It is thought that the Warburg effect is irreversible in cancer cells, while in 
inflammation, the effect seems to be reversible 
77
. Here, in this study cells were 
challenged with or without LPS for 19 h after 5 h pre-treatment of 400 µg/ml acerola 
fractions. Macrophages were stimulated with LPS that increased the Warburg effect 
however acerola samples were unable to decrease these levels, so the levels were 
maintained. One plausible explanation is that acerola leaf or fruit extracts (for both 
solvents) were unable to scavenge ROS completely after 19 h, nor were they able to 
affect the glycolysis pathway or the Krebs cycle, thereby they were unable to bioreduce 
tetrazolium salt into formazan and thus acerola could not reverse the Warburg effect 
(Figure 3.5).  
Selective inhibition of Cyclooxygenase-2 enzyme activity 
NSAID drugs are traditionally used by targeting cyclooxygenases. 
Cyclooxygenase exists in two isoforms COX-1 and COX-2 and are responsible for 
production of prostaglandins, prostacyclin’s and thromboxane’s. COX-1 is expressed 
constitutively and is responsible for the maintenance of the homeostasis whereas COX-2 
is induced during inflammation and proliferative diseases. Stimulus like LPS and 
overexpression of cytokines mediates expression of COX-2 for biosynthesis of 
prostaglandins, prostacyclin and thromboxane 
68, 80, 81
.  
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Arachidonic acid undergoes peroxidase and cyclooxygenase action which lead to 
production of prostaglandins H2. Cayman COX inhibitor screening assay directly 
measures PGF2α produced by SnCl2 reduction of COX-derived PGH2. The results are 
quantified by a plate reader assay. 
Acerola leaf extracts showed strong inhibition of COX-2 enzyme expression 
(Figure 3.6 A). On the other hand, the action of COX-2 enzyme was attenuated by fruits 
as well, but BRS-238 had a stronger inhibition as compared to other extracts (Figure 3.6 
B). BRS-238 ripe fruit and other leaf samples suggest that a possible mechanism of 
action is through inhibition of COX-2 activity in a mechanism similar to that of an 
NSAIDs 
82, 83
. So further, to pinpoint the genotype with a selective mode of action COX-
1 enzyme activity was measured for all leaf samples (BRS 186, BRS 235, BRS 236, 
BRS 237, BRS 238, BRS 366) and BRS 238 sample of fruit species. The leaf extracts 
from acerola demonstrated suppression in the COX-1 activity making them potent 
NSAID drugs with non-selective cyclooxygenase inhibition, like aspirin 
82, 83
. However, 
in BRS-238 fruit a selective inhibition was observed (Figure 3.7 A).  BRS-238 does not 
trigger the COX-1 enzyme activity but inhibited the action of COX-2 enzyme only 
(Figure3.7 B) , proposing that consumption of acerola genotype BRS-238 ripe fruit not 
only is a source of antioxidants but can also substitute NSAID commercial drugs like 
Diclofenac, Celecoibs and ibuprofen 
70
. COX inhibitors bind to both isozyme- COX-1 
and COX-2.Their kinetics reckons on the bond inhibitors develops with cyclooxygenases 
depending upon time. Supposing a bond between the isozyme and the inhibitor is 
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irreversible then the inhibitors are termed as non-selective. However, in case of 
selectivity the bond dissociates from with one of the isozyme quicker than the other. 
71
.   
CONCLUSION 
Results exhibited an increase in ROS due to induction by LPS which was further 
reduced by methanolic extracts of leaf and few ripe fruit genotypes after 4 h or 19 h 
stimulation of LPS; however, in the case of MeOH/Acetone/water extracts, the levels of 
ROS were partially suppressed mainly at 19 h. Since only leaf methanolic extracts 
showed a reduction of ROS levels at 4h, there was a partial reduction in NO production 
for these samples as well. For all other acerola extracts, the NO production was not 
altered. It is likely that the mixture of terpenoids/polyphenols present in the methanolic 
leaf samples played a role in the response of ROS and NO reduction. 
During inflammation, LPS binds to the TLR4 receptor and triggers ROS 
dependent NF-ĸB activation. NF-ĸB is translocated via IκB and Ref-1 into the nucleus 
where it mediates the gene expression of COX-2 and iNOS 
21, 72
. iNOS mediates 
production of nitric oxide and cyclooxygenases (prostaglandin endoperoxide H synthase-
1 and 2) are known to catalyze the synthesis of prostaglanoids. Prostaglandin E-2 and D-
2 are produced during inflammation for resolution of inflammation 
68
. In a previous 
study with macrophages, acerola leaves and ripe fruit genotype BRS-238 exhibited 
suppression in the production of PGE2 in cell lysates 
84
. In the present study we 
observed a drastic decrease in COX-2 (enzyme upstream of prostaglandins) enzymatic 
activity confirming that the suppressed level of PGH2α by acerola genotypes takes place 
in in-vitro cell assays as well as in biochemical enzymatic assays (Figure 3.8).  
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Non-steroidal anti-inflammatory drugs (NSAID) are involved in a range of 
pathologies for inflammation. Inhibitory effect of COX-2 and COX-1 by acerola leaf and 
fruit extracts for a range of genotypes in this project indicates its potential to be used as a 
natural source of NSAID.   
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
Evidences have established a pivotal role of macrophages in metabolic syndrome 
18
. Being the key effector cells they are known to maintain homoeostasis by efferocytosis 
that is eradicating the necrotic cells 
15-17
.  
They have been used as a model cell line for understanding pathogenesis of 
chronic inflammation and preventing them utilizing various metabolites from plants, 
ceramide and different drugs. They elicit inflammatory responses by increasing the 
metabolic stress during maladaptation through a feed forward signaling pathway leading 
to activation of various transcription factors. They induce various cytokines like TNF-α, 
IL-1β, IL-10, IFNγ and IL-4 16, 19.  
In the presence of external stress LPS, pathogen is recognized by a pattern 
recognition receptor TLR-4 resulting in its upregulation. This ligation initiates 
production of copious ROS and NO 
26
. ROS is known to be produced from mitochondria 
and NADPH oxidase. Complex I and III are known to be involved in production 
superoxide radicals. NADPH oxidase in presence of endogenous stimuli converts O2 to 
O2
.-
. These superoxide radicals are further converted into hydrogen peroxide (H2O2) by 
action of superoxide dismutase. H2O2 is well  known to impact the gene expression and 
proliferation in stressed macrophages 
25, 85
. iNOS (inducible isoform of nitric oxide 
synthase) gene responsible for high throughput production nitric oxide in presence of 
LPS. Nitric oxide levels are also stimulated by cytokines TNF-α, IL-1β and IFN-γ when 
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macrophages are activated and NO levels increase exponentially after 6 h. IFN-β is an 
autocrine and paracrine activator for iNOS gene which induces JAK/STAT and IRF 
signaling pathway 
21
. 
The crosstalk between ROS/NO and NF-κB has been studied to understand 
insight mechanism of inflammation. Activation of NF- κB is mediated by Ref-1 (redox 
factor-1) which induces gene expression of various pro-inflammatory markers 
26
. 
This investigation explores to measure at two different time intervals and 
analyzes the effect of acerola on the basis of ROS and NO in presence of external 
stimuli.  Results from early ROS indicate the action of acerola on ROS produced from 
NADPH. Whereas late ROS are mediated by action of TNF-α and other cytokines. 
Interestingly, acerola showcases suppression of ROS howbeit there is no or partial 
suppression for the levels of nitric oxide. As explained above, ROS mediates 
transcription of NF-ĸB which advocates iNOS gene which further fabricates nitric oxide. 
This connotes that ROS and NO, two redox factors are linked. Acerola’s putative 
mechanism may involve suppression of ROS from NADPH oxidase whereas it was 
unable to suppress the ROS produced from mitochondria. Exhorting the fact that ROS 
was still being produced which promoted NO levels.  
 The extraction process by two different solvents bestows a comparative analysis 
on the basis of the phytochemicals that are being involved in scavenging ROS in case of 
acerola. Phenolics with or without presence of terpenes are known to scavenge ROS.  
Yet in this study phenolics alone could not scavenge the ROS however phenolics along 
with terpenoids scavenged ROS at early and late stimulation of LPS. This confirmed the 
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hypothesis that either terpene alone or synergistically is involved in imparting the 
antioxidant activity.  
Further analysis on COX enzyme inhibition activity was measured using the 
fractions including terpenes and phenolic both. It was observed that all acerola fractions 
could suppress COX-2 enzyme expression; however the effect seen by acerola leaf were 
more poignant as compared with fruits. COX-1 enzyme activity was further measured 
for leaf fraction and one genotype of fruit sample. All leaf samples demonstrated a 
mechanism similar to traditional NSAID drugs where they block both COX levels by 
binding to the active site in the C-terminal of cyclooxygenases and block the production 
of prostaglandins making them not selective. Howbeit fruit sample (BRS-238) manifests 
a selective COX-2 inhibitor which means that probably it does not bind to the active site 
of cyclooxygenase C-terminal and bind to some other side pocket enhancing its activity 
over traditional NSAIDs 
69
.  
FUTURE RECOMMENDATIONS 
Acerola’s mechanism associated with inhibition COX enzyme expression needs 
to be elucidated. Acerola could be both binding to enzyme itself and further inhibiting 
the expression of prostaglandins or it could be suppressing the gene associated with 
COX. According to this study, acerola methanolic leaf fractions are capable of inhibiting 
the enzymatic activity of COX-1 and 2. One possibility is that acerola binds at the 
catalytic site of the cyclooxygenase enzyme, in a similar mechanism that of aspirin. Or 
another possibility could be that acerola suppresses the cyclooxygenases expression. 
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Chemical analysis of acerola fraction is required to determine the underlying role of 
individual phytochemical responsible for the biological analysis.  
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APPENDIX 
 
Figure 2.1. Systematic flowchart for TLC 
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Table 2.1. Terpenoid and steroid screening using TLC in 10% DCM. 
Secondary Metabolite Solvent combination for extraction 
 
Methanol 
MeOH: Acetone 
(1:1) 
MeOH:Acetone:water 
(5:4:1) 
Terpenoids/Steroids +++ +++ + 
Secondary Metabolite Solvent combination for extraction 
 
After hexane extraction 
Methanol 
MeOH: Acetone 
(1:1) 
MeOH:Acetone:water 
(5:4:1) 
Terpenoids/Steroids + + - 
Secondary Metabolite Solvent combination for extraction 
 
chloroform treatment on the residues 
Methanol 
MeOH: Acetone 
(1:1) 
MeOH:Acetone:water 
(5:4:1) 
Terpenoids/Steroids + + - 
Secondary Metabolite Solvent combination for extraction 
 
Hexane fractions 
Methanol 
MeOH: Acetone 
(1:1) 
MeOH:Acetone:water 
(5:4:1) 
Terpenoids/Steroids - - - 
+++ Strong intensity reaction, ++ Moderate intensity reaction; + Weak intensity 
reaction; - Non-detected 
F2 
F3 
F1 
F4 
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Figure 2.2. HPLC/MS profile of Acerola Leaves genotypes 
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Table 2.2.Identified components from the Acerola leaves extract 
Peak 
no 
Retention 
time 
UV 
MS 
[M-H]
-
 
MS
2
 Identification 
1 31.8 
253,328, 
352 
711 579,285 
kaempferol 3-O-β-D-[- 
arabinopyranosyl-(1'''→2'')-O-α-L-
apiose-(1''''→5'')-O-β-Dglucopyranoside  
2 33.2 
242,271, 
382 
725 
593,392, 
285, 
Kaempferol 3-O-robinobioside-7-O-
arabinofuranoside 
3 33.43 
242,265, 
299,353 
755 
623,605, 
490,357, 
315 
3'-methoxyquercetin-7-O-α-L-
rhamnopyranosyl-3-O-α-
arabinofuranosyl-(1→6)-β-D-
glucopyranoside 
4 34.58 
242,266, 
307,348 
579 285 kaempferol O-glycosides 
5 34.84 
242,266, 
345 
579 285 kaempferol O-glycosides 
6 35.48 
242,266, 
347 
609 301 Rutin 
7 36.99 
242,266, 
345 
593 447,285 Kaempferol 7-O-neohesperidoside 
8 37.74 
253,328, 
354 
623 315,242 isorhamnetin 3-O-rutinoside 
9 40.73 
230,242, 
270,312 
917/459 711,693 - 
10 41.16 
253,328, 
354 
931 
739,725, 
707,605, 
298 
- 
11 42.19 
253,328, 
354 
785 593,313 digalloyl-HHDP-glucose 
12 42.64 
230,242, 
270, 315 
857 693 - 
13 43.10 
230,242, 
270,315 
871 
751,725, 
707, 441 
- 
Structure of Kaempferol 
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Figure 2.3. HPLC/MS profile of Acerola fruits genotypes  
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Table 2.3. Identification of components from acerola fruits genotypes 
Peak 
no 
Reten
tion 
time 
UV MS 
[M+
H] 
MS/
MS 
Identification BRS 
186 
BRS 
235 
BRS 
236 
BRS 
237 
BRS 
238 
BRS 
366 
1 
26.5 
208, 
510 
433 270 
Cyanidin 3-
rhamnoside 
+ + + + + + 
2 
27.3 
208, 
510 
417 287 
Pelargonidin 
3-rhamnoside 
+ + + + + + 
3 
28.4 
208, 
510 
327 301 
Unknown 
Peonidin 
derivative 
+ + + + + + 
4 
31.0 
208, 
510 
596 
449, 
287 
Cyanidin 3-
rutinoside 
+ + + + + + 
5 
31.7 
208, 
510 
451 
303, 
316 
Peonidin-3-
xylopyranosid
e 
+ + + + + + 
6 
44.5 
208, 
510 
464 301 
Peonidin 3-
glucoside 
+ - + + - + 
7 
46.6 348 448 285 
Kaempferol 3-
O-glucoside 
+ + + + + + 
8 50.8 - 383 303 - - + + - + - 
9 
53.2 
266, 
349, 
478 
610 
464, 
301 
Peonidin 3-
rutinoside 
- - + + + - 
10 
56.4 
241, 
310 
424 
339, 
423, 
365 
- 
- - + - + - 
11 
62.1 
241, 
264, 
322 
641 
627, 
464, 
316 
Peonidin-3-O-
diglucoside 
- - + - + - 
Structure of Peonidin 
 
R 
Glucoside 
Rutinoside 
Diglucoside 
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Figure 3.1. Effect of Acerola on cell viability in macrophage cells 
RAW 264.7 cells (0.5×10
5
 cells/well in 96-well culture plates) were pretreated with 400 µg/ml 
Acerola samples for 5 h and then stimulated with LPS (1 µg/ml) for 19 h. The cell viability was 
measured using microplate reader (Synergy HT, Bio-Tek Instruments, Inc., Winooski, 
VT) with the MTS CellTiter 96®AQueous One Solution. The 0 µg/ml is a control, indicating 
the pretreatment of 0.5 % DMSO in DMEM medium without any LPS stimulation. Data, 
obtained from triplicate repeats at least, are shown as mean ± SE. Different letters indicate 
significant differences by the ANOVA/Student's t-test (p < 0.05). 
(A) Methanolic extracts (A.1) leaf and (A.2) fruits; (B) methanol/acetone/water (B.1) leaf and 
(B.2) fruits. 
 (A.1) 
 (A.2) 
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Figure 3.1. Continued 
 (B.1) 
 (B.2) 
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Figure 3.2. Effect of Acerola on LPS-induced ROS production for 4 h. 
RAW264.7 cells (0.5×10
5
 cells/well in 96-well culture plates) were pretreated with 400 µg/ml 
Acerola samples for 5 h and then stimulated with LPS (1 µg/ml) for 4 h. DCFA was used to 
determine the generation of intracellular ROS.  The 0 µg/ml is a control, indicating the 
pretreatment of 0.5 % DMSO in DMEM medium without any LPS stimulation. Data, obtained 
from triplicate repeats at least, are shown as mean ± SE. Different letters indicate significant 
differences by the ANOVA/Student's t-test (p < 0.05). 
(A) Methanolic extracts (A.1) leaf and (A.2) fruits; (B) methanol/acetone/water (B.1) leaf and 
(B.2) fruits. 
 (A.1) 
 (A.2) 
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Figure 3.2. Continued 
 (B.1) 
 (B.2) 
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Figure 3.3. Effect of Acerola on LPS-induced ROS production for 19 h. 
RAW264.7 cells (0.5×10
5
 cells/well in 96-well culture plates) were pretreated with 400 µg/ml 
Acerola samples for 5 h and then stimulated with LPS (1 µg/ml) for 19 h. DCFA was used to 
determine the generation of intracellular ROS.  The 0 µg/ml is a control, indicating the 
pretreatment of 0.5 % DMSO in DMEM medium without any LPS stimulation. Data, obtained 
from triplicate repeats at least, are shown as mean ± SE. Different letters indicate significant 
differences by the ANOVA/Student's t-test (p < 0.05).  
(A) Methanolic extracts (A.1) leaf and (A.2) fruits; (B) methanol/acetone/water (B.1) leaf and 
(B.2) fruits.    
 (A.1) 
 (A.2) 
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Figure 3.3. Continued  
 (B.1) 
 (B.2) 
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Figure 3.4. Effect of Acerola on LPS-induced NO production. 
RAW264.7 cells (0.5×10
5
 cells/well in 96-well culture plates) were pretreated with 400 µg/ml 
Acerola samples for 5 h and then stimulated with LPS (1 µg/ml) for 19 h. Griess reagent was 
used to detect the generation of extracellular nitrite 19 h after the LPS challengeThe 0 µg/ml is a 
control, indicating the pretreatment of 0.5 % DMSO in DMEM medium without any LPS 
stimulation. Data, obtained from triplicate repeats at least, are shown as mean ± SE. Different 
letters indicate significant differences by the ANOVA/Student's t-test (p < 0.05). 
 (A) Methanolic extracts (A.1) leaf and (A.2) fruits; (B) methanol/acetone/water (B.1) leaf and 
(B.2) fruits.    
 (A.1) 
 (A.2) 
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Figure 3.4. Continued 
 (B.1) 
 (B.2) 
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Figure 3.5. Effect of Acerola on mitochondrial activity after LPS stimulation. 
RAW 264.7 cells (0.5×10
5
 cells/well in 96-well culture plates) were pretreated with 400 µg/ml 
Acerola samples 5 h and then stimulated with LPS (1 µg/ml) for 19 h. MTS assay was performed 
to determine the mitochondrial activity as described in materials and methods. The 0 µg/ml is a 
control, indicating the pretreatment of 0.5 % DMSO in DMEM medium without any LPS 
stimulation. Data, obtained from triplicate repeats at least, are shown as mean ± SE. Different 
letters indicate significant differences by the ANOVA/Student's t-test (p < 0.05). 
(A) Methanolic extracts (A.1) leaf and (A.2) fruits; (B) methanol/acetone/water (B.1) leaf and 
(B.2) fruits. 
 (A.1) 
 (A.2) 
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Figure 3.5. Continued 
 (B.1) 
 (B.2) 
  
67 
 
 
 
Figure 3.6. Effect of Acerola on COX-2 enzyme activity. 
According to the instruction of COX Inhibitor Screening Assay Kit (Cayman Chemical, Ann 
Arbor, MI), COX-2 enzyme was incubated with 200 µg/ml Acerola leaf and fruit methanolic 
extracts and then its activity was examined by measuring the level of PGE2α. DuP-607 was used 
as a positive control for COX-2 reaction. Data, obtained from three biological repeats at least, 
are shown as mean ± SE values. Different letters indicate significant differences by the 
ANOVA/Student's t-test (p < 0.05). Methanolic extracts (A.1) leaf and (A.2) fruits 
 (A.1) 
 (A.2) 
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Figure 3.7. Effect of Acerola on COX-1 enzyme activity. 
 According to the instruction of COX Inhibitor Screening Assay Kit (Cayman Chemical, Ann 
Arbor, MI), COX-1 enzyme was incubated with 200 µg/ml Acerola leaf and fruit extracts and 
then its activity was examined by measuring the level of PGE2α. Data, obtained from three 
biological repeats at least, are shown as mean ± SE values. Different letters indicate significant 
differences by the ANOVA/Student's t-test (p < 0.05). 
(A.1) Leaf (BRS-186, BRS-235, BRS-236, BRS-237, BRS-238, BRS-366) and Fruit (BRS-238) 
(A.2) COX 1 and 2 combined. 
 (A.1) 
 (A.2) 
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Figure 3.8. Proposed model of action of methanolic genotypes of acerola 
LPS binds to the TLR-4 receptor, fostering ROS from NADPH oxidases and mitochondria. ROS 
initiates activation of NF-ĸB and induces COX-2 and amplification of the iNOS expressions. 
Methanolic extracts of acerola genotypes partially scavenged ROS at 19 h LPS treatment and the 
leaf fractions partially attenuated nitric oxide levels. Acerola genotypes displayed inhibitory 
action of COX-1 and COX-2 enzyme activity. However, BRS-238 fruit fraction displayed 
selectivity and suppressed enzyme activity of only COX-2.  Here, green and purple color 
signifies the leaf and fruit genotypes respectively. 
 
